Dai Mengjun, Li Kangbo, Sacirovic Mesud, Zemmrich Claudia, Ritter Oliver, Bramlage Peter, Persson Anja Bondke, Buschmann Eva, Buschmann Ivo, Hillmeister Philipp
Department for Angiology, Center for Internal Medicine I, Deutsches Angiologie Zentrum Brandenburg - Berlin (DAZB), University Clinic Brandenburg, Brandenburg Medical School Theodor Fontane, Brandenburg an der Havel, Germany.
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany.
Sci Rep. 2024 Dec 5;14(1):30390. doi: 10.1038/s41598-024-76686-2.
This retrospective study explored the association between circulating cell-free plasma telomere length (cf-TL) and coronary artery disease (CAD) and heart failure (HF). Data from 518 participants were collected, including clinical and laboratory data. cf-TL was measured in plasma samples and machine learning (ML) classification models were developed to differentiate between CAD, HF and control conditions. Our results showed that cf-TL was significantly prolonged in HF patients compared to controls, but no significant difference was observed between CAD patients and controls. Additionally, cf-TL was significantly correlated with nitric oxide metabolites (NOx) and flow-mediated dilation (FMD), suggesting a potential link with endothelial function. To avoid data leakage and ensure the model captured only relationships relevant to the research question, we utilized a temporal data split, holding out the last year's data for testing (n = 81) and using the remaining data for training (n = 324) and validation (n = 109). The ML models using four variables achieved an area under the curve (AUC) of 0.795 in the validation dataset and 0.717 in the test dataset for CAD classification, and 0.829 in the validation dataset and 0.806 in the test dataset for HF classification. SHAP analysis revealed that cf-TL had minimal impact on the predictions of the CAD model, as indicated by consistently low SHAP values, whereas in the HF model, cf-TL exhibited a broader range of SHAP values, indicating a greater contribution to the model's classification. These findings suggest that cf-TL may play a more prominent role in HF pathophysiology and could serve as a valuable biomarker for predicting HF risk. Further studies are warranted to explore cf-TL's diagnostic and prognostic potential across different cardiovascular diseases.
这项回顾性研究探讨了循环无细胞血浆端粒长度(cf-TL)与冠状动脉疾病(CAD)和心力衰竭(HF)之间的关联。收集了518名参与者的数据,包括临床和实验室数据。在血浆样本中测量cf-TL,并开发机器学习(ML)分类模型以区分CAD、HF和对照情况。我们的结果表明,与对照组相比,HF患者的cf-TL显著延长,但CAD患者与对照组之间未观察到显著差异。此外,cf-TL与一氧化氮代谢产物(NOx)和血流介导的扩张(FMD)显著相关,表明与内皮功能存在潜在联系。为避免数据泄露并确保模型仅捕捉与研究问题相关的关系,我们采用了时间数据分割,留出最后一年的数据用于测试(n = 81),并使用其余数据进行训练(n = 324)和验证(n = 109)。使用四个变量的ML模型在验证数据集中对CAD分类的曲线下面积(AUC)为0.795,在测试数据集中为0.717;对HF分类在验证数据集中的AUC为0.829,在测试数据集中为0.806。SHAP分析显示,cf-TL对CAD模型预测的影响最小,SHAP值始终较低,而在HF模型中,cf-TL的SHAP值范围更广,表明对模型分类的贡献更大。这些发现表明,cf-TL可能在HF病理生理学中发挥更突出的作用,并可作为预测HF风险的有价值生物标志物。有必要进一步研究探索cf-TL在不同心血管疾病中的诊断和预后潜力。